Resignation of Interim CFO: Pursuant to the approval accorded by the Board of Directors at its meeting held on May 19, 2026, for the appointment of Mr. Sanjeev Kumar as the Chief Financial Officer and Key Managerial Personnel of the Company, and consequent upon his assumption of office with effect from May 25, 2026, Dr. Manish Mattoo, Executive Director and Chief Executive Officer of the Company, has relinquished the additional charge of Interim Chief Financial Officer of the Company with effect from May 25, 2026.
HCG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.0 pts less than Nifty Microcap 250 and 0.3 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Healthcare Global Enterprises Limited (HCG) announced that Dr. Manish Mattoo, who also serves as Executive Director and CEO, has stepped down from the additional charge of Interim Chief Financial Officer effective May 25, 2026. This resignation follows the appointment of Mr. Sanjeev Kumar as the permanent Chief Financial Officer and Key Managerial Personnel (KMP) of the company, whose appointment was approved by the Board of Directors on May 19, 2026, and assumed office on May 25, 2026. Dr. Mattoo had been holding the Interim CFO role since December 1, 2025, until a new CFO was appointed. He will continue in his role as Executive Director and CEO of the company.
This is a routine executive transition following the appointment of a permanent CFO. Dr. Mattoo remains as CEO, so there is no leadership void. The company has successfully transitioned from interim to permanent CFO arrangements, which should bring stability to the finance function.